Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
Peter Pickkers, MD, PhD
Alexander Zarbock, MD
Cases in Acute Kidney Injury: Applications for Clinical Practice
Mark Dunbar, OD, FAAO
Diana V. Do, MD
A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19
A National Eye Institute Initiative—Ensuring the Health of Patients and Staff...
Diana Shechtman, OD, FAAO
Charles Wykoff, MD, PhD
A National Eye Institute Initiative—Practice Strategies to Optimize Continuity of Care for Eye Health During COVID-19
A National Eye Institute Initiative—Practice Strategies to Optimize Continuit...
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Brian P. McDonough, MD, FAAFP
How Primary Care Clinicians on the Frontline Are Managing Patients During the COVID-19 Pandemic
How Primary Care Clinicians on the Frontline Are Managing Patients During the...
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
C. Michael Gibson, MD, MS
COVID-19 & Cardiovascular Considerations
Jay L. Koyner, MD
John A. Kellum, MD, MCCM
Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
Ravindra L. Mehta, MD
Rajit K. Basu, MD, MS, FCCM
Acute Kidney Injury: Finding a Pathway to Improved Patient Outcomes
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (L...
Kathy King, RDN
Kristin Kirkpatrick, MS, RDN
Skinny Liver: A Closer Examination of Fatty Liver Disease
FDA’s Role in Foreign Drug Manufacturing
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Ser...
Matt Rosenberg, MD
Aiden Harrington, ANP, CNM
STI Screening & Counseling Strategies for Transgender Patients
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Stay current with the best on medical education
We’re glad to see you’re enjoying Prova Education…but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.